Southridge Partners has secured an option to buy a stake in Stevia Corp.
The two companies announced today (1 February) that they have signed an equity purchase agreement for Southridge to acquire up to US$20m of Stevia’s registered common stock. The funding will enable Stevia Corp to “further accelerate its development of the alternative sweetener stevia”, it said.
Go deeper with GlobalData
Under the terms of the agreement, Stevia Corp has the right to sell up to $20m of its common stock to Southridge “from time to time” over a 36-month period.
Southridge is an institutional investor based in Ridgefield, Connecticut.
“This is an important milestone for Stevia Corp to have accomplished,” said Stevia Corp’s president, George Blankenbaker. “Having a flexible and low-cost funding instrument in place allows us to efficiently accelerate our commercialisation and acquisition strategies.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
